Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 2
2014 4
2015 1
2017 1
2019 1
2021 1
2022 2
2023 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Interventions for enhancing medication adherence.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, Agoritsas T, Mistry N, Iorio A, Jack S, Sivaramalingam B, Iserman E, Mustafa RA, Jedraszewski D, Cotoi C, Haynes RB. Nieuwlaat R, et al. Among authors: iserman e. Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4. Cochrane Database Syst Rev. 2014. PMID: 25412402 Free PMC article.
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective study.
Matino D, Iorio A, Keepanasseril A, Germini F, Caillaud A, Carcao M, Hews-Girard J, Iserman E, James P, Lee A, Phua CW, Sun HL, Teitel J, Poon MC. Matino D, et al. Among authors: iserman e. Res Pract Thromb Haemost. 2022 Mar 31;6(3):e12661. doi: 10.1002/rth2.12661. eCollection 2022 Mar. Res Pract Thromb Haemost. 2022. PMID: 35386274 Free PMC article.
Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes.
Iorio A, MacDonald V, Caillaud A, Luckevich MD, Christoffersen P, Matino D, Keepanasseril A, Iserman E, Germini F, Bentley A, Poon MC. Iorio A, et al. Among authors: iserman e. Res Pract Thromb Haemost. 2023 Mar 11;7(3):100106. doi: 10.1016/j.rpth.2023.100106. eCollection 2023 Mar. Res Pract Thromb Haemost. 2023. PMID: 37065846 Free PMC article.
Terminal half-life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database.
Versloot O, Iserman E, Chelle P, Germini F, Edginton AN, Schutgens REG, Iorio A, Fischer K; Pharmacokinetic (PK) Expert Working Group of the International Prophylaxis Study Group (IPSG). Versloot O, et al. Among authors: iserman e. J Thromb Haemost. 2021 Aug;19(8):1896-1906. doi: 10.1111/jth.15395. Epub 2021 Jun 18. J Thromb Haemost. 2021. PMID: 34013558 Free PMC article.
20 results